273 related articles for article (PubMed ID: 16521119)
1. Investigation of the phase diagrams of chiral praziquantel.
Liu Y; Wang X; Wang JK; Ching CB
Chirality; 2006 May; 18(4):259-64. PubMed ID: 16521119
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical properties, binary and ternary phase diagrams of ketoprofen.
Hong Lu Y; Bun Ching C
Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization and enantioseparation of the chiral compound praziquantel.
Liu Y; Wang X; Wang JK; Ching CB
J Pharm Sci; 2004 Dec; 93(12):3039-46. PubMed ID: 15514924
[TBL] [Abstract][Full Text] [Related]
4. Solubility properties of racemic praziquantel and its enantiomers.
el-Arini SK; Giron D; Leuenberger H
Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
[TBL] [Abstract][Full Text] [Related]
5. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
[TBL] [Abstract][Full Text] [Related]
6. Solubility of molecular crystals: polymorphism in the light of solubility theory.
Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
[TBL] [Abstract][Full Text] [Related]
7. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
Huang J; Chen S; Guzei IA; Yu L
J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
[TBL] [Abstract][Full Text] [Related]
9. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.
Choobdari E; Fakhraian H; Peyrovi MH
Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075
[TBL] [Abstract][Full Text] [Related]
10. Application of direct crystallization for racemic compound propranolol hydrochloride.
Wang X; Lu J; Ching CB
J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
[TBL] [Abstract][Full Text] [Related]
11. The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.
van Eupen JT; Westheim R; Deij MA; Meekes H; Bennema P; Vlieg E
Int J Pharm; 2009 Feb; 368(1-2):146-53. PubMed ID: 18996456
[TBL] [Abstract][Full Text] [Related]
12. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
13. Modeling and prediction of cocrystal phase diagrams.
Ainouz A; Authelin JR; Billot P; Lieberman H
Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure, thermal behavior and enzymatic degradation of poly(tetramethylene adipate) solution-grown chain-folded lamellar crystals.
Iwata T; Kobayashi S; Tabata K; Yonezawa N; Doi Y
Macromol Biosci; 2004 Mar; 4(3):296-307. PubMed ID: 15468220
[TBL] [Abstract][Full Text] [Related]
15. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
16. Melting point and phase diagram of methanol as obtained from computer simulations of the OPLS model.
Gonzalez Salgado D; Vega C
J Chem Phys; 2010 Mar; 132(9):094505. PubMed ID: 20210403
[TBL] [Abstract][Full Text] [Related]
17. [Influence of mobile phase composition on chiral separation of albendazole sulfoxide racemates].
Zhai Z; Zhang H; Dun H; Liu C; Chen L; Li Y
Se Pu; 2004 May; 22(3):244-7. PubMed ID: 15712908
[TBL] [Abstract][Full Text] [Related]
18. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
Wang XJ; Wiehler H; Ching CB
Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
[TBL] [Abstract][Full Text] [Related]
19. Preferential enrichment: full crystallographic analysis of the unusual phenomenon in the mixed crystals' version.
Takahashi H; Tamura R; Fujimoto D; Lepp Z; Kobayashi K; Ushio T
Chirality; 2002 Jul; 14(7):541-7. PubMed ID: 12112325
[TBL] [Abstract][Full Text] [Related]
20. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
